[HTML][HTML] Bone–cartilage interface crosstalk in osteoarthritis: potential pathways and future therapeutic strategies

XL Yuan, HY Meng, YC Wang, J Peng, QY Guo… - Osteoarthritis and …, 2014 - Elsevier
Currently, osteoarthritis (OA) is considered a disease of the entire joint, which is not simply a
process of wear and tear but rather abnormal remodelling and joint failure of an organ. The …

[HTML][HTML] Interplay between cartilage and subchondral bone contributing to pathogenesis of osteoarthritis

AR Sharma, S Jagga, SS Lee, JS Nam - International journal of molecular …, 2013 - mdpi.com
Osteoarthritis (OA) is a common debilitating joint disorder, affecting large sections of the
population with significant disability and impaired quality of life. During OA, functional units …

Subchondral bone as a key target for osteoarthritis treatment

S Castañeda, JA Roman-Blas, R Largo… - Biochemical …, 2012 - Elsevier
Osteoarthritis (OA), the most common form of arthritis, is a debilitating and progressive
disease that has become a major cause of disability and impaired quality of life in the …

Rank/Rankl/opg: literature review.

I Silva, JC Branco - Acta reumatologica portuguesa, 2011 - search.ebscohost.com
The discovery of the receptor activator of nuclear factor-kB (RANK)/RANK Ligand (RANKL)/
osteoprotegerin (OPG) pathway contributed to the understanding of how bone formation and …

[HTML][HTML] Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis

M Bellido, L Lugo, JA Roman-Blas, S Castañeda… - Arthritis research & …, 2010 - Springer
Introduction Osteoporosis (OP) increases cartilage damage in a combined rabbit model of
OP and osteoarthritis (OA). Accordingly, we assessed whether microstructure impairment at …

[HTML][HTML] Disease-modifying effects of COX-2 selective inhibitors and non-selective NSAIDs in osteoarthritis: a systematic review

K Nakata, T Hanai, Y Take, T Osada, T Tsuchiya… - Osteoarthritis and …, 2018 - Elsevier
Osteoarthritis (OA) is a potentially disabling disease whose progression is dependent on
several risk factors. OA management usually involves the use of non-steroidal anti …

[HTML][HTML] E-type prostanoid receptor 4 (EP4) in disease and therapy

V Konya, G Marsche, R Schuligoi… - Pharmacology & …, 2013 - Elsevier
The large variety of biological functions governed by prostaglandin (PG) E2 is mediated by
signaling through four distinct E-type prostanoid (EP) receptors. The availability of mouse …

The interleukin-1 system and female reproduction

N Gérard, M Caillaud, A Martoriati… - Journal of …, 2004 - joe.bioscientifica.com
Betacellulin, a member of the epidermal growth factor (EGF) family, was originally isolated
and identified from the conditioned medium from a murine pancreatic beta-cell carcinoma …

[HTML][HTML] Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis

M Bellido, L Lugo, JA Roman-Blas, S Castaneda… - Osteoarthritis and …, 2011 - Elsevier
PURPOSE: Impairment of subchondral bone density and quality aggravates cartilage
damage in osteoarthritis (OA). Accordingly, we assessed whether improving microstructure …

[HTML][HTML] Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis

MC Zweers, TN de Boer, J van Roon… - Arthritis research & …, 2011 - Springer
Osteoarthritis (OA) is a degenerative joint disease characterized by progressive loss of
articular cartilage, subchondral bone sclerosis, osteophyte formation, and synovial …